Association of the human bradykinin B2 receptor gene with chronic renal failure
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Introduction The kallikrein-kinin system plays an important role in blood pressure homeostasis and renal sodium regulation, and some studies have reported that the kinins have a protective effect against hypertension and the development of renal disease. The B2-bradykinin receptor (B2R) mediates the majority of physiological actions of bradykinin. We investigated the effect of the C181-->T polymorphism in exon 2 of the B2R gene in patients with end-stage renal disease (ESRD).Methods This study involved 790 patients with ESRD and 510 healthy controls. All participants were genotyped for the B2R C181-->T polymorphism by PCR followed by digestion of a PCR product with TaqI restriction endonuclease. DNA fragments were separated by agarose gel electrophoresis. Genotype and allele frequencies were compared between the groups. All calculations were performed using SPSS 5.0 for Windows.Results B2R genotype distribution in patients and controls was in accordance with Hardy-Weinberg equilibrium. The frequency of the T allele was higher in ESRD patients than in controls. The significant difference was observed in the age at onset of renal disease; for patients with the T allele the mean age at onset was 36.8 years, compared with 52.4 years for those carrying only the C allele (p<0.001). The frequencies of the T allele and carrier genotypes were not associated with gender, presence of hypertension, or underlying kidney disease.Conclusion Our results suggest that the B2R polymorphism has a potential role in the earlier development of chronic renal failure in susceptible individuals. We did not confirm the previously published reports that the B2R gene polymorphism has a protective role in the development of ESRD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistently, polymorphisms in KKS-related genes (ACE, BDKRB2, NOS3, KLK1) are associated with an increased risk of acute and chronic renal injury in humans [22–25].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [25]
Citations
Cites
The effects of storage of blood and isolated DNA on the integrity of DNA
Madisen, L., Hoar, D. I., Holroyd, C. D., Crisp, M., Hodes, M. E., & Reynolds, J. F. (1987) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320270216 · Cited by 265
Prado, G. N., Taylor, L., Zhou, X., Ricupero, D., Mierke, D. F., & Polgar, P. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10175 · Cited by 177
BULUK, K., Zuch, A., & Czokało, M. (1972) · PubMed · Cited by 137
Margolius, H. S. (1995) · Hypertension · doi:10.1161/01.hyp.26.2.221 · Cited by 110
Braun, A. D., Kammerer, S., Maier, E. M., Böhme, E., & Roscher, A. A. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00079-3 · Cited by 83
Hypotension in Transgenic Mice Overexpressing Human Bradykinin B2Receptor
Wang, D.-Z., Chao, L., & Chao, J. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.488 · Cited by 83
Kinins in the cardiovascular system
Schölkens, B. A. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00061-6 · Cited by 70
Structure and signalling pathways of kinin receptors
Blaukat, A. (2003) · Andrologia · doi:10.1046/j.1439-0272.2003.00533.x · Cited by 70
Kinin receptors: functional aspects
Marceau, F., Sabourin, T., Houle, S., Fortin, J., Petitclerc, É., Molinaro, G., & Adam, A. A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00189-3 · Cited by 64
Renovascular Hypertension in Bradykinin B2-Receptor Knockout Mice
Madeddu, P. R., Milia, A. F., Salis, M. B., Gaspa, L., Gross, W., Lippoldt, A., & Emanueli, C. (1998) · Hypertension · doi:10.1161/01.hyp.32.3.503 · Cited by 63
Cited by
The kallikrein-kinin system in health and in diseases of the kidney
Kakoki, M., & Smithies, O. (2009) · Kidney International · doi:10.1038/ki.2008.647 · Cited by 106
Participation of kallikrein–kinin system in different pathologies
Costa-Neto, C. M., Dillenburg-Pilla, P., Heinrich, T. A., Parreiras‐e‐Silva, L. T., Pereira, M. G. A. G., Reis, R. I., & de Souza, P. C. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.08.003 · Cited by 94
Unraveling the Pivotal Role of Bradykinin in ACE Inhibitor Activity
Taddei, S., & Bortolotto, L. A. (2016) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-016-0173-4 · Cited by 104
Chao, J., Bledsoe, G., Yin, H. H., & Chao, L. (2006) · Biological Chemistry · doi:10.1515/bc.2006.085 · Cited by 77
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types
Tailor, P. D., Kodeboyina, S. K., Bai, S., Patel, N., Sharma, S., Ratnani, A., Copland, J. A., She, J., & Sharma, A. K. (2018) · Oncotarget · doi:10.18632/oncotarget.24947 · Cited by 66
Gebbink, M. F. B. G., Bouma, B., Maas, C., & Bouma, B. N. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.06.013 · Cited by 55
The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney
Ramani, K., Garg, A. V., Jawale, C. V., Conti, H. R., Whibley, N., Jackson, E. K., Shiva, S. S., Horne, W., Kolls, J. K., Gaffen, S. L., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005952 · Cited by 43
Ramani, K., Jawale, C. V., Verma, A. H., Coleman, B. M., Kolls, J. K., & Biswas, P. S. (2018) · JCI Insight · doi:10.1172/jci.insight.98241 · Cited by 34
Ramani, K., Tan, R. J., Zhou, D. F., Coleman, B. M., Jawale, C. V., Liu, Y., & Biswas, P. S. (2018) · Mediators of Inflammation · doi:10.1155/2018/5103672 · Cited by 33
Global Renal Gene Expression Profiling Analysis in B2-Kinin Receptor Null Mice: Impact of Diabetes
Jaffa, M. A., Kobeissy, F. H., Hariri, M. A., Chalhoub, H., Eid, A. A., Ziyadeh, F. N., & Jaffa, A. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044714 · Cited by 24
“Polymorphisms in the human B2R have been linked to increased albuminuria in diabetic patients and to the development of chronic renal failure [28,29].”
BackgroundYang, J. W., Hutchinson, I. V., Shah, T., Fang, J., & Min, D. I. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0376-8 · Cited by 15
“Despite this evidence, only a limited number of genes have been studied for their association with hypertensive nephropathy (Table 1) [16–21].”
BackgroundGirolami, J., Blaes, N., Bouby, N., & Alhenc‐Gelas, F. (2014) · Springer eBooks · doi:10.1007/978-3-319-06683-7_6 · Cited by 10
Vasoactive Molecules and the Kidney
Gilbert, R. E., Game, D. S., & Advani, A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10012-0 · Cited by 9
Review on Molecular Mechanism of Hypertensive Nephropathy
Peng, Z., Xu, Q., Hu, W.-L., & Cheng, Y. (2023) · Current Pharmaceutical Design · doi:10.2174/0113816128266582231031111516 · Cited by 9
The kallikrein–kinin system in diabetic kidney disease
Liu, W., Stanton, R. C., & Zhang, Z. (2017) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000344 · Cited by 12
Recent Developments in the Regulation of Kinins
Sharma, J. N. (2014) · Springer eBooks · doi:10.1007/978-3-319-06683-7 · Cited by 5
Vasoactive Substances As Mediators of Renal Injury*
Gupta, M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00810-1 · Cited by 2
Msallem, J. A., Chalhoub, H., Al-Hariri, M., Saad, L., Jaffa, M. A., Ziyadeh, F. N., & Jaffa, A. A. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00233.2015 · Cited by 1
RetractedVasoactive Substances as Mediators of Renal Injury
Gupta, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100601-6.00810-3 · Cited by 1
The Mechanism of Activation of the Contact System and Fibrinolytic System
Maas, C., Health, C., Laboratorium, C. D., de Groot, F., Bouma, B. N., & Gebbink, M. F. B. G. (2009) · Amyloid · doi:10.1080/13506120902879954 · Cited by 1
Factor XII Deficiency or Hageman Factor Deficiency
Stavrou, E. X., & Schmaier, A. H. (2014) · Wiley eBooks · doi:10.1002/9781118833391.ch9
Role of ACE Inhibitors in Transforming Renin–Angiotensin System
Nandave, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-7380-0_4
López‐Lera, A., Corvillo, F., González-Sánchez, L., Melgosa, M., & Sánchez‐Corral, P. (2025) · Nefrología · doi:10.1016/j.nefro.2025.501347
Tracing the historical journey: milestones and highlights of bradykinin
Couture, R., Othman, R., Talbot, S., & Girolami, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-28907-1.00001-3
López‐Lera, A., Corvillo, F., González-Sánchez, L., Melgosa, M., & Sánchez‐Corral, P. (2025) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2025.501347 · Cited by 1
“42 The effects of the BK-B2R interaction contrast with those observed in the des-Arg9-BK-B1R interaction.”
Ardiles, L. G., & Figueroa, C. D. (2026) · Drugs and Drug Candidates · doi:10.3390/ddc5010013 · Cited by 1
“Reduced kallikrein levels in patients with mild or advanced renal failure are of particular relevance [37,38], as are human data associating a higher incidence of chronic renal failure to the presence of polymorphisms in the kallikrein [39] and kinin B2R genes [40].”
Metadata
- Authors
- Jozwiak, L., Drop, A., Buraczynska, K., Ksiazek, P., Mierzicki, P., & Buraczynska, M.
- Affiliations
- Medical University of Lublin (PL)
- ORCID
- Drop, Andrzej
- Venue
- Molecular Diagnosis
- Published
- 2004-09
- Volume
- 8
- Issue
- 3
- Pages
- 157-161
- ISSN
- 1084-8592 (ISSN-L)
- OpenAlex
- W2087816099
- Cited by
- 26
- References
- 28
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 1 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 3 · 2012: 2
- FWCI
- 0.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Molecular Diagnosis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- bradykinin B2 receptor, end-stage renal disease, chronic kidney disease, kallikrein-kinin system, genetic susceptibility, hypertension
- MeSH terms
- Adult, Exons, Female, Humans, Kidney Failure, Chronic, Male, Polymorphism, Genetic, Kallikrein-Kinin System, Genetic Predisposition to Disease, Receptor, Bradykinin B2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.